Patients are increasingly holding doctors to account by bringing NICE guidance with them to consultations. Debate at NICE's annual conference …
AstraZeneca's chief executive David Brennan says the pharmaceutical industry could be one of the top performing sectors during the global …
The pharmaceutical industry has hit back at what it says is an ill-informed attack on the sector by the European …
Boehringer Ingelheim's consumer arm has applied to make its urological disorder drug Flomax (tamsulosin) available in the UK from pharmacists …
Cancer death rates in England have dropped and one-year survival rates are up, according to the Department of Health. But …
One of MedImmune's key products has hit a delay in the US, after regulators demanded further data. The FDA asked …
The first of a new generation of primary care centres has been opened in Bradford, which the government hopes will …
When the UK's Olympics team came home from Beijing this summer, laden with a record haul of medals, the nation …
The election of Barack Obama has brought high expectations, with his "Change Can Happen" mantra signaling to many that a …
Japanese company Daiichi Sankyo is continuing its expansion in Europe with the launch of operations in Ireland.The new subsidiary's headquarters …
The European pharmaceutical industry could shortly face a major inquiry into its practices, with the European Commission ready to reveal …
The first new oral centrally acting analgesic in more than 25 years has been approved in the US.Tapentadol was developed …
Bristol-Myers Squibb's breast cancer drug Ixempra has suffered a setback in the EU over safety concerns.The Committee for Medicinal Products …
The government is looking to the NHS to produce huge new savings as part of its rescue package for the …
European regulators have recommended Roche's RoActemra be approved to treat moderate to severe rheumatoid arthritis. The novel drug, known as …
Doctors and nurses are to decide on a series of quality indicators that will measure how well the NHS is …
Personal health records will play an important role in the exchange of health informationEarly successes in healthcare interoperability are paving …
The future of UK medicines could be revolutionised by a new deal that contains two pioneering measures on flexible prices …